Skip to content

Veradermics, Inc

MANE

CIK 0001827635

← back to feed
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$70M
−164.3% YoY Q1 May 2026
EPS Diluted (TTM)
−$111.91
−202.1% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$71.63M
Q1 May 2026
Cash
$168.41M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
41.78M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings